WDR5 inhibitor (Shanghai Blueray Biopharma)

N/A

Report date: 2025/06/11 10:38:58
NME

Base Information

Drug NameWDR5 inhibitor (Shanghai Blueray Biopharma)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionWD repeat-containing protein 5 degraders
TargetsWD repeat-containing protein 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Blueray Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Blueray Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A